Mirae Asset Global Investments’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$93.2K Buy
+3,394
New +$90.2K ﹤0.01% 1248
2026
Q1
Sell
-2,840
Closed -$87.5K 1646
2025
Q4
$87.5K Buy
2,840
+1,219
+75% +$38K ﹤0.01% 1287
2025
Q3
$49.7K Buy
1,621
+1
+0.1% +$24 ﹤0.01% 1341
2025
Q2
$33.5K Sell
1,620
-30,383
-95% -$624K ﹤0.01% 1314
2025
Q1
$630K Sell
32,003
-17,724
-36% -$372K ﹤0.01% 886
2024
Q4
$1.03M Buy
49,727
+34,652
+230% +$761K ﹤0.01% 812
2024
Q3
$367K Buy
15,075
+265
+2% +$7.08K ﹤0.01% 1004
2024
Q2
$379K Buy
14,810
+7
+0% +$198 ﹤0.01% 962
2024
Q1
$443K Sell
14,803
-5,103
-26% -$150K ﹤0.01% 1954
2023
Q4
$634K Buy
19,906
+62
+0.3% +$1.95K ﹤0.01% 1854
2023
Q3
$700K Sell
19,844
-1,987
-9% -$75.7K ﹤0.01% 1718
2023
Q2
$830K Sell
21,831
-2,039
-9% -$81.3K ﹤0.01% 1681
2023
Q1
$901K Sell
23,870
-21,850
-48% -$840K ﹤0.01% 1601
2022
Q4
$1.94M Sell
45,720
-11,848
-21% -$488K 0.01% 1161
2022
Q3
$1.84M Sell
57,568
-56,764
-50% -$1.99M 0.01% 1171
2022
Q2
$2.58M Buy
114,332
+59,300
+108% +$1.92M 0.01% 1063
2022
Q1
$1.99M Sell
55,032
-607
-1% -$20.8K ﹤0.01% 1156
2021
Q4
$2.21M Sell
55,639
-61
-0.1% -$2.54K ﹤0.01% 1104
2021
Q3
$2.43M Buy
55,700
+5,736
+11% +$258K 0.01% 1061
2021
Q2
$2.04M Sell
49,964
-10,206
-17% -$394K 0.01% 1053
2021
Q1
$1.98M Buy
60,170
+17,081
+40% +$642K 0.01% 959
2020
Q4
$1.75M Buy
+43,089
New +$1.61M 0.01% 970

Other funds holding GMAB

Mirae Asset Global Investments's GMAB Position: Q2 2026 in Review

Mirae Asset Global Investments opened a new position in Genmab (GMAB) in Q2 2026: 3,394 shares worth $93.2K. The stake represents ﹤0.01% of the portfolio and ranks #1248 among its holdings. This is a return to the name: Mirae Asset Global Investments previously reported a position in GMAB as recently as Q4 2025.

Mirae Asset Global Investments first reported a position in GMAB in Q4 2020 and has held it in 22 quarters since. The position peaked at $2.58M in Q2 2022. 122 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Mirae Asset Global Investments held 3,394 shares of Genmab worth $93.2K as of Q2 2026.
  • Genmab was a new Mirae Asset Global Investments position in Q2 2026.
  • Genmab made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1248 holding.
  • Mirae Asset Global Investments first reported a position in Genmab in Q4 2020 and has held it in 22 quarters since.
  • Mirae Asset Global Investments's Genmab position peaked at $2.58M in Q2 2022.
  • 122 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.